Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 2.72
ICAD's Cash to Debt is ranked higher than
62% of the 1737 Companies
in the Global Software - Application industry.

( Industry Median: 4.76 vs. ICAD: 2.72 )
ICAD' s 10-Year Cash to Debt Range
Min: 0.03   Max: No Debt
Current: 2.72

Equity to Asset 0.64
ICAD's Equity to Asset is ranked higher than
70% of the 1699 Companies
in the Global Software - Application industry.

( Industry Median: 0.59 vs. ICAD: 0.64 )
ICAD' s 10-Year Equity to Asset Range
Min: 0.25   Max: 0.92
Current: 0.64

0.25
0.92
F-Score: 4
Z-Score: 1.44
M-Score: -2.05
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -4.50
ICAD's Operating margin (%) is ranked higher than
50% of the 1731 Companies
in the Global Software - Application industry.

( Industry Median: 5.56 vs. ICAD: -4.50 )
ICAD' s 10-Year Operating margin (%) Range
Min: -187.4   Max: 12.71
Current: -4.5

-187.4
12.71
Net-margin (%) -17.37
ICAD's Net-margin (%) is ranked lower than
55% of the 1731 Companies
in the Global Software - Application industry.

( Industry Median: 3.87 vs. ICAD: -17.37 )
ICAD' s 10-Year Net-margin (%) Range
Min: -188.36   Max: 11.62
Current: -17.37

-188.36
11.62
ROE (%) -17.65
ICAD's ROE (%) is ranked lower than
55% of the 1695 Companies
in the Global Software - Application industry.

( Industry Median: 6.78 vs. ICAD: -17.65 )
ICAD' s 10-Year ROE (%) Range
Min: -150.94   Max: 7.57
Current: -17.65

-150.94
7.57
ROA (%) -8.99
ICAD's ROA (%) is ranked lower than
53% of the 1743 Companies
in the Global Software - Application industry.

( Industry Median: 3.80 vs. ICAD: -8.99 )
ICAD' s 10-Year ROA (%) Range
Min: -66.12   Max: 6.46
Current: -8.99

-66.12
6.46
ROC (Joel Greenblatt) (%) -97.55
ICAD's ROC (Joel Greenblatt) (%) is ranked lower than
55% of the 1737 Companies
in the Global Software - Application industry.

( Industry Median: 30.27 vs. ICAD: -97.55 )
ICAD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1593.65   Max: 174.45
Current: -97.55

-1593.65
174.45
Revenue Growth (%) -5.40
ICAD's Revenue Growth (%) is ranked higher than
52% of the 1428 Companies
in the Global Software - Application industry.

( Industry Median: 6.40 vs. ICAD: -5.40 )
ICAD' s 10-Year Revenue Growth (%) Range
Min: -41.4   Max: 31.4
Current: -5.4

-41.4
31.4
EBITDA Growth (%) 207.20
ICAD's EBITDA Growth (%) is ranked higher than
100% of the 1159 Companies
in the Global Software - Application industry.

( Industry Median: 8.30 vs. ICAD: 207.20 )
ICAD' s 10-Year EBITDA Growth (%) Range
Min: -75.1   Max: 207.2
Current: 207.2

-75.1
207.2
EPS Growth (%) 58.10
ICAD's EPS Growth (%) is ranked higher than
94% of the 1111 Companies
in the Global Software - Application industry.

( Industry Median: 7.60 vs. ICAD: 58.10 )
ICAD' s 10-Year EPS Growth (%) Range
Min: -47.9   Max: 58.1
Current: 58.1

-47.9
58.1
» ICAD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

ICAD Guru Trades in Q3 2013

Jim Simons 272,160 sh (+4.73%)
» More
Q4 2013

ICAD Guru Trades in Q4 2013

Jim Simons 347,060 sh (+27.52%)
» More
Q1 2014

ICAD Guru Trades in Q1 2014

Jim Simons 351,460 sh (+1.27%)
» More
Q2 2014

ICAD Guru Trades in Q2 2014

Jim Simons 292,260 sh (-16.84%)
» More
» Details

Insider Trades

Latest Guru Trades with ICAD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Lee Ainslie 2013-03-31 Sold Out $4.42 - $6.64 $ 9.9288%0
Lee Ainslie 2012-12-31 New Buy$1.91 - $4.8 $ 9.92221%6791
Lee Ainslie 2012-09-30 Sold Out 0.0012%$1.9 - $2.89 $ 9.92347%0
Lee Ainslie 2012-03-31 Reduce -24.08%$2.35 - $3.4 $ 9.92282%184141
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 2.67
ICAD's P/B is ranked higher than
68% of the 1856 Companies
in the Global Software - Application industry.

( Industry Median: 2.84 vs. ICAD: 2.67 )
ICAD' s 10-Year P/B Range
Min: 0.43   Max: 6.56
Current: 2.67

0.43
6.56
P/S 3.26
ICAD's P/S is ranked higher than
60% of the 1856 Companies
in the Global Software - Application industry.

( Industry Median: 2.33 vs. ICAD: 3.26 )
ICAD' s 10-Year P/S Range
Min: 0.76   Max: 24.26
Current: 3.26

0.76
24.26
EV-to-EBIT -84.65
ICAD's EV-to-EBIT is ranked higher than
53% of the 1856 Companies
in the Global Software - Application industry.

( Industry Median: 33.78 vs. ICAD: -84.65 )
ICAD' s 10-Year EV-to-EBIT Range
Min: 5.8   Max: 897.3
Current: -84.65

5.8
897.3
Current Ratio 2.47
ICAD's Current Ratio is ranked higher than
75% of the 1723 Companies
in the Global Software - Application industry.

( Industry Median: 1.90 vs. ICAD: 2.47 )
ICAD' s 10-Year Current Ratio Range
Min: 0.57   Max: 3.85
Current: 2.47

0.57
3.85
Quick Ratio 2.37
ICAD's Quick Ratio is ranked higher than
75% of the 1723 Companies
in the Global Software - Application industry.

( Industry Median: 1.78 vs. ICAD: 2.37 )
ICAD' s 10-Year Quick Ratio Range
Min: 0.44   Max: 3.33
Current: 2.37

0.44
3.33

Valuation & Return

vs
industry
vs
history
Price/Net Cash 28.35
ICAD's Price/Net Cash is ranked higher than
84% of the 1856 Companies
in the Global Software - Application industry.

( Industry Median: 9999.00 vs. ICAD: 28.35 )
ICAD' s 10-Year Price/Net Cash Range
Min: 5.99   Max: 279.38
Current: 28.35

5.99
279.38
Price/Net Current Asset Value 10.66
ICAD's Price/Net Current Asset Value is ranked higher than
84% of the 1856 Companies
in the Global Software - Application industry.

( Industry Median: 9999.00 vs. ICAD: 10.66 )
ICAD' s 10-Year Price/Net Current Asset Value Range
Min: 3.67   Max: 241.67
Current: 10.66

3.67
241.67
Price/Tangible Book 7.46
ICAD's Price/Tangible Book is ranked higher than
64% of the 1856 Companies
in the Global Software - Application industry.

( Industry Median: 7.20 vs. ICAD: 7.46 )
ICAD' s 10-Year Price/Tangible Book Range
Min: 2.61   Max: 322.5
Current: 7.46

2.61
322.5
Price/DCF (Projected) 9.18
ICAD's Price/DCF (Projected) is ranked higher than
71% of the 1856 Companies
in the Global Software - Application industry.

( Industry Median: 6.50 vs. ICAD: 9.18 )
ICAD' s 10-Year Price/DCF (Projected) Range
Min: 0.95   Max: 175.67
Current: 9.18

0.95
175.67
Price/Median PS Value 1.11
ICAD's Price/Median PS Value is ranked higher than
71% of the 1856 Companies
in the Global Software - Application industry.

( Industry Median: 1.17 vs. ICAD: 1.11 )
ICAD' s 10-Year Price/Median PS Value Range
Min: 0.29   Max: 7.37
Current: 1.11

0.29
7.37
Earnings Yield (Greenblatt) 0.20
ICAD's Earnings Yield (Greenblatt) is ranked lower than
63% of the 1476 Companies
in the Global Software - Application industry.

( Industry Median: 5.70 vs. ICAD: 0.20 )
ICAD' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 17.2
Current: 0.2

0.1
17.2
Forward Rate of Return (Yacktman) -0.92
ICAD's Forward Rate of Return (Yacktman) is ranked higher than
59% of the 1311 Companies
in the Global Software - Application industry.

( Industry Median: 5.18 vs. ICAD: -0.92 )
ICAD' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -11.1   Max: -2.5
Current: -0.92

-11.1
-2.5

Business Description

Industry: Application Software » Software - Application
Compare:CRM, SQI, RHT, INTU, ADBE » details
Traded in other countries:HWT1.Germany
Icad Inc., is incorporated in Delaware corp. The Company is a provider of advanced image analysis and workflow solutions that enable radiologists and other healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. It high-performance, expandable Computer-Aided Detection (CAD) systems and workflow solutions for mammography, such as film-based, digital radiography (DR), in addition to computed radiography (CR), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). It offers a comprehensive range of high-performance upgradeable products for use with mammography, including digital radiography, computed radiography and film-based mammography. These solutions enable radiologists to better serve patients by identifying pathologies and pinpointing cancers. The company's solutions aid in the early detection of the prevalent cancers including breast, prostate and colon cancer. Early detection of cancer is the key to better prognosis, less invasive and lower treatment costs, and higher survival rates. The company's products are manufactured and assembled for it by a contract manufacturer of medical devices. Its manufacturing efforts are generally limited to purchasing and supply chain management, planning/scheduling, manufacturing engineering, service repairs, quality assurance, inventory management, and warehousing. Its products are sold through its direct regional sales organization in the U.S. as well as through its OEM partners, including GE Healthcare, Fuji Medical Systems, Siemens Medical, Philips Healthcare, Agfa Corporation, Sectra Medical Systems, Planmed, Fuji Medical Systems, IMS Giotto, and Carestream. The Company currently faces direct competition in its CAD business from Hologic, Inc. and imaging equipment manufacturers such as GE Healthcare, Siemens Medical, and Philips Medical Systems. The Company's systems are medical devices subject to extensive regulation by the FDA under the Federal Food, Drug, and Cosmetic Act with potentially significant costs for compliance.
» More Articles for ICAD

Headlines

Articles On GuruFocus.com
Weekly CFO Buys Highlight: MCP, ICAD, BODY, VVTV, MCRI Sep 03 2012 
Weekly CFO Buys Highlight: BWEN, SGGH, ICAD, CMLS, MCP Aug 27 2012 
icad inc. Reports Operating Results (10-Q) Nov 09 2010 
icad inc. Reports Operating Results (10-Q) Aug 06 2010 
icad inc. (icad) Executive VP of Finance, CFO Darlene M Deptula-hicks sells 25,000 Shares Mar 11 2010 
icad inc. Reports Operating Results (10-Q) Aug 10 2009 
icad inc. Reports Operating Results (10-Q) May 08 2009 
iCAD To Host Fourth Quarter and Fiscal Year 2008 Financial Results Conference Call on Thursday, Febr Jan 29 2009 

More From Other Websites
ICAD INC Files SEC form 8-K/A, Financial Statements and Exhibits Oct 01 2014
ICAD INC Files SEC form 8-K/A, Financial Statements and Exhibits Sep 30 2014
INVESTOR ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into iCAD Inc.... Sep 18 2014
iCAD to Present at the 5th Annual Craig-Hallum Alpha Select Conference Sep 17 2014
iCAD to Showcase its Comprehensive Electronic Brachytherapy Solutions and Services at 56th Annual... Sep 11 2014
iCAD Expands Partnership with Volpara Solutions to Offer Enhanced Breast Imaging Analytics for 2D... Sep 04 2014
ICAD INC Financials Aug 22 2014
ICAD INC Files SEC form 10-Q, Quarterly Report Aug 14 2014
ICAD INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and... Aug 01 2014
ICAD: 25% Revenue Growth. Therapy Biz Remains On A Tear Jul 31 2014
iCAD Reports Second Quarter Financial Results Jul 30 2014
Q2 2014 iCAD Inc Earnings Release - After Market Close Jul 30 2014
iCAD to Host Second Quarter 2014 Financial Results Conference Call on Wednesday, July 30, 2014 Jul 22 2014
ICAD INC Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and... Jul 18 2014
ICAD: DermEbx/Radion Acquisition Looks Like a Real Win Jul 17 2014
iCAD Inc Business Update Call scheduled for 8:30 pm ET today Jul 15 2014
iCAD acquires DermEbx, Radion for $12.6M in cash, stock Jul 15 2014
iCAD Acquires DermEbx and Radion to Provide Powerful Comprehensive Skin Cancer Treatment Solution to... Jul 15 2014
3 Stocks Under $10 Making Big Moves Jul 11 2014
Pentagon Awards $127 Million in Defense Contracts May 28 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK